Does Dr. KATINA VARZOS have financial conflicts of interest?

Dr. KATINA VARZOS (CNM, PMHNP) has received a total of $357 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $357 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. KATINA VARZOS?

According to CMS Open Payments data, Dr. KATINA VARZOS received funding from OTSUKA AMERICA PHARMACEUTICAL ($125), TRIS PHARMA ($124), and JANSSEN PHARMACEUTICALS ($107).

Does Dr. KATINA VARZOS receive research grants or speaking fees?

Dr. KATINA VARZOS has received $357 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. KATINA VARZOS

CNM, PMHNPReal-Time Hydrated

Specialty: Nurse Practitioner, Psych/Mental Health

Practice Location: GUILFORD, CT 06437

NPI Number: 1932126398

LIFETIME INDUSTRY VALUE

$357

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. VARZOS is a verified Nurse Practitioner, Psych/Mental Health practitioner based in GUILFORD, CT.

Between 2021 and 2025, Dr. VARZOS had an overall industry promotional and research financial footprint of $357 as recorded in the federal CMS Open Payments database.

$357 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. VARZOS's primary funding source is OTSUKA AMERICA PHARMACEUTICAL, which accounts for $125 (representing 35.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OTSUKA AMERICA PHARMACEUTICAL

Rank 1

$125

35.1%

TRIS PHARMA

Rank 2

$124

34.9%

JANSSEN PHARMACEUTICALS

Rank 3

$107

30.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.